Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07027878 · ClinicalTrials.gov registry record
JETi Lower Extremity Venous Thrombosis
A clinical trial of Venous Thrombosis, sponsored by Abbott Medical Devices.
- Active
- Registry status
- 121
- Enrollment target
- 20
- Study locations
NCT07027878 is a study of Venous Thrombosis that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 121 participants, below the 1,112-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT07027878, a study of Venous Thrombosis, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- 121 participants
- Enrollment target
- 20
- Study locations
Study Summary
The JETi Registry is a prospective, single-arm, multicenter study to collect real-world data on the safety, performance, and clinical benefits of the JETi System for the treatment of acute and subacute thrombosis in the peripheral vasculature. This is a post-market study that will register approximately 280 subjects at approximately 30 centers globally. Subjects participating in this registry will be followed through their 12-month follow up visit.
Conditions Studied
Interventions
- DEVICE JETi lower extremity venous thrombosis
Study Locations (20)
California
- PIH Good Samaritan - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Stanford University Hospital and Clinics - Palo Alto
Colorado
- University of Colorado - Aurora
- ClinRé - Thornton
New York
- Weill Cornell Medicine - New York
- Mount Sinai Hospital - New York
Oklahoma
- Ascension St. John Jane Phillips - Bartlesville
- Hightower Clinical - Oklahoma City
Arizona
- HonorHealth - Scottsdale
Arkansas
- Arkansas Heart Hospital - Little Rock
Indiana
- St. Mary Medical Center - Hobart
Iowa
- Midwest Cardiovascular Research Foundation - Davenport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2025-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07027878
The ClinicalTrials.gov registry entry for NCT07027878 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,112-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (89% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which JETi lower extremity venous thrombosis is the first listed.
NCT07027878 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT07027878 about?
NCT07027878 is a clinical study titled "JETi Lower Extremity Venous Thrombosis". The JETi Registry is a prospective, single-arm, multicenter study to collect real-world data on the safety, performance, and clinical benefits of the JETi System for the treatment of acute and subacute thrombosis in the peripheral vasculature. This is a post-market study that will register approxima...
What is the current status of trial NCT07027878?
This trial is currently active not recruiting. The enrollment target is 121 participants. The study started on 2020-03-06. Estimated completion is 2025-08.
What conditions does trial NCT07027878 study?
This clinical trial studies the following conditions: Venous Thrombosis.
What interventions are being tested in trial NCT07027878?
The interventions under investigation include: JETi lower extremity venous thrombosis (DEVICE).
Who is sponsoring clinical trial NCT07027878?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07027878 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
COMPLETED · NA
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
COMPLETED · NA
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.